Results 31 to 40 of about 34,610 (287)

Current incidence of certain clostridial infections: gas gangrene and tetanus

open access: yesБиопрепараты: Профилактика, диагностика, лечение, 2021
Clostridial myonecrosis or gas gangrene (myonecrosis) and tetanus are relatively rare nowadays, but they are still considered serious conditions associated with poor prognosis and high mortality.
E. I. Komarovskaya, O. V. Perelygina
doaj   +1 more source

Genomics of the Pathogenic Clostridia

open access: yesMicrobiology Spectrum, 2019
ABSTRACT Whole-genome sequences are now available for all the clinically important clostridia and many of the lesser or opportunistically pathogenic clostridia. The complex clade structures of C. difficile , C.
Robert J, Moore, Jake A, Lacey
openaire   +2 more sources

Biotechnological Approaches to Generate Biogenic Solvents and Energy Carriers from Renewable Resources

open access: yesThe EuroBiotech Journal, 2023
Background: Current threats connected to the ongoing depletion of fossil resources and elevated levels of greenhouse gases accelerating climate change and global warming provoke a renaissance of biotechnological production of various organic bulk ...
Koller Martin
doaj   +1 more source

Assessing the usefulness of clostridia spores for evaluating sewage sludge hygienization [PDF]

open access: yes, 2017
The capability of clostridia spores to act as pathogen indicators in sewage sludge treatment was investigated. Sulfite-reducing clostridia and E. coli levels were monitored during waste activated sludge pre-treatments (alkali and ultrasound) and its ...
Lucena, Francisco   +3 more
core   +3 more sources

Natural Product Discovery from Solventogenic Clostridia [PDF]

open access: yes, 2020
Secondary metabolites, or natural products, are small molecules which frequently possess biological activities and are a critically important resource for the development of new pharmaceuticals, pigments, and agrochemicals.
Li, Jeffrey S
core   +1 more source

The human gut microbiome across the life course

open access: yesFEBS Letters, EarlyView.
Despite significant individual variation and continuous change throughout life, the human gut microbiome follows some life stage‐specific trends. This article provides a brief overview of how gut microbiome composition shifts across different phases of life. Created in BioRender. Özkurt, E. (2026) https://BioRender.com/8q4nrnc.
Alise J. Ponsero   +4 more
wiley   +1 more source

Selective Growth Inhibitory Effect of Biochanin A Against Intestinal Tract Colonizing Bacteria

open access: yesMolecules, 2010
Both bifidobacteria and clostridia are part of the natural gut microflora and while clostridia may be responsible for severe intestinal infections, bifidobacteria are probiotic microorganisms belonging to the most important prospective bacteria in the ...
Olga Sklenickova   +5 more
doaj   +1 more source

Microbiome‐blood–brain barrier interactions in aging — mechanisms and therapeutic potential

open access: yesFEBS Letters, EarlyView.
Aging reshapes the gut microbiome (↓SCFA‐producing commensals; ↑pro‐inflammatory outputs), shifting circulating metabolites (↓SCFAs; ↑LPS, ↑TMAO, ↑PAA) that act at the BBB to increase nonspecific transcytosis, alter transport, and promote astrocyte reactivity, heightening brain vulnerability.
Daniel Cuervo‐Zanatta   +3 more
wiley   +1 more source

Spore Preparation Protocol for Enrichment of Clostridia from Murine Intestine [PDF]

open access: yes, 2017
In recent years, many spore-forming commensal Clostridia found in the gut have been discovered to promote host physiology, immune development, and protection against infections.
Eric Velazquez   +5 more
core   +1 more source

Structure‐forward targeting of claudins with synthetic binders

open access: yesFEBS Letters, EarlyView.
Claudins form the paracellular barriers between epithelial and endothelial tissues at tight junctions and are targets for molecular binders with the goal of modulating barrier permeability. Claudin‐binding molecules are relevant in drug delivery or in altering claudin interactions with disease‐causing proteins.
Alex J. Vecchio
wiley   +1 more source

Home - About - Disclaimer - Privacy